Skip to main content
246 search results for:

Prognosis 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 24-01-2023 | Teaser
    Live webinar

    Advances in urothelial cancer treatment and prognosis

    This independent medical education meeting has been funded by Astellas.

  2. 05-08-2022 | Teaser
    On-demand webcast

    Advances in prostate cancer treatment and prognosis

    This independent medical education meeting has been funded by Astellas.

  3. 24-04-2022 | Gastrointestinal stromal tumors | Adis Journal Club | Article
    Advances in Therapy

    Clinicopathologic Characteristics and Prognosis of PDGFRA-Mutant Gastrointestinal Stromal Tumors: A Large-Scale, Multi-Institutional, Observational Study in China

    PDGFRA -mutant GIST mostly originated in the stomach and had a favorable prognosis after surgery. 

  4. 28-04-2022 | Breast cancer | Adis Journal Club | Article
    Advances in Therapy

    High Expression of C8orf76 Is an Independent Predictive Factor of Poor Prognosis in Patients with Breast Cancer

    Conclusions High C8orf76 expression may be a valuable biomarker related to the diagnosis and prognosis of patients with breast cancer.

  5. 27-01-2022 | Breast cancer | News | Article

    Genetic ultralow-risk breast cancers ‘have the best prognosis

    Individuals with 70-gene signature ultralow-risk breast cancers have excellent prognosis and could be candidates for de-escalated treatment.

  6. 18-03-2021 | Adis Journal Club | Article
    Targeted Oncology

    Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA

    Randomized clinical trials are needed to establish how to integrate liquid biopsy to improve the prognosis of patients affected by metastatic colorectal cancer.

  7. 24-12-2020 | Breast cancer | News | Article

    HRQoL effects of breast cancer prognosis, treatment predict mortality risk

    The health-related quality of life of patients with ductal carcinoma in situ or invasive breast cancer is impaired by their prognosis and treatment, and measuring the extent of impairment could help predict mortality risk, research suggests.

  8. 16-12-2020 | SABCS 2020 | Conference coverage | Article

    Integrated tool may individualize prognosis prediction in early breast cancer

    A prognostic tool that integrates clinicopathologic and genomic data provides more information on distant recurrence risk than either feature alone, and can estimate absolute chemotherapy benefit in individual patients with node-negative breast cancer, say researchers.

  9. 28-08-2020 | Immunotherapy | News | Article

    ICI-associated low blood counts linked to poor stage IV cancer prognosis

    Within 3 months of initiating ICI treatment, 7.4% of patients developed incident thrombocytopenia and 10.2% developed anemia, which were both associated with poor prognosis.

  10. 01-07-2020 | Breast cancer | News | Article

    Timing of diagnosis impacts interval breast cancer prognosis

    Zhenzhen Zhang (OHSU Knight Cancer Institute, Portland) and co-investigators say the poor prognosis “might not be due to delayed diagnosis but rather to distinct biological characteristics associated with the cancer.”

  11. 26-10-2023 | Toxicities | Teaser

    Looking for coverage of ESMO 2023?

    There's a new home for news and congress coverage! Catch up on all the top stories and latest evidence in oncology research with our ESMO congress hub page.  Learn more »

  12. 06-10-2023 | Prostate cancer | News | Article

    Add-on SBRT improves outcomes of men with oligometastatic CRPC

    They note that at the time of analysis, patients had been followed up for a median of 24.9 months, and therefore “these data may require more time to mature, especially given the good prognosis of the population studied (oligometastatic patients without visceral metastases).”

  13. 23-04-2020 | Comorbidities | News | Article

    New York City study reports on prognosis of cancer patients with COVID-19

    Age appears to be a key factor modifying the prognosis of people with cancer who acquire COVID-19, findings indicate.

  14. 13-09-2023 | Immunotherapy | News | Article

    Cutaneous irAEs tied to improved survival after ICI treatment

    The researchers explain that “[a]lthough numerous systematic reviews and meta-analyses have investigated the emergence of irAEs and their association with treatment effectiveness and survival outcomes, there has been a paucity of reviews examining potential associations between [cutaneous] irAE emergence and prognosis among patients receiving ICI treatment.”

  15. 28-07-2023 | Non-small-cell lung cancer | News | Article

    Atezolizumab may be beneficial for platinum-ineligible advanced NSCLC

    With regard to safety, the team highlights that “no new or unexpected adverse events were identified with atezolizumab in this poor-prognosis population.”

  16. 25-05-2018 | Colorectal cancer | News | Article

    Worse prognosis for patients with V600E BRAF-mutated colorectal liver metastases

    The presence of the BRAF V600E mutation in colorectal liver metastases is associated with a worse prognosis and increased risk for recurrence, according to findings from an international retrospective cohort study.

  17. 26-07-2017 | Teaser

    Advances in understanding prognosis in myeloma

    This review article summarizes current concepts of prognostic markers in myeloma. Summary points Response to myeloma treatment and survival remains heterogeneous, with some patients living for 1–2 years whilst others are alive and progression-free at 10 years. This variation in outcome is due to patient characteristics plus features intrinsic to the myeloma tumor. Alongside the introduction of novel therapies there has been a greater understanding of disease biology and mechanisms of resistance. This has led to an increase in the number of prognostic markers that can be used in myeloma. This is important not only for more accurate counselling of patients in terms of disease outcome, but also in paving the way for risk-adapted therapy. Indeed, the prognostic value of certain markers varies according to which therapy the patient receives. These prognostic factors will require constant re-evaluation as agents with new mechanisms of action are added into the myeloma treatment algorithm. Smith D & Yong K.  Br J Haematol  2016; 175: 367–380. doi: 10.1111/bjh.14304

  18. 29-11-2017 | Prognosis | News | Article

    Prognosis discussions do not disrupt the patient–physician relationship

    Discussing a patient’s prognosis does not harm the patient–physician relationship and may even be beneficial, according to findings from a US-based cohort study.

  19. 01-02-2017 | Article

    Advances in understanding prognosis in myeloma

    This review article summarizes current concepts of prognostic markers in myeloma. Smith D & Yong K.  Br J Haematol  2016; 175: 367–380. doi: 10.1111/bjh.14304

  20. 23-06-2017 | Breast cancer | News | Article

    Adjuvant capecitabine improves prognosis in high-risk breast cancer

    Patients with residual invasive disease after standard neoadjuvant chemotherapy for HER2-negative breast cancer benefit from adjuvant treatment with capecitabine, CREATE-X trial data show.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.